RSS   Newsletter   Contact   Advertise with us
Post Online Media

KalVista Pharma appoints Andreas Maetzel as SVP

KalVista PharmaKalVista Pharmaceuticals, a clinical stage pharmaceutical company, announced the appointment of Andreas Maetzel to the role of senior vice president, medical.
Article continues below

READ MORE KalVista Pharma appoints Edward P. Feener as CSO

Dr. Maetzel was most recently Vice President, Global Medical Affairs at BioCryst Pharmaceuticals.

Prior to that he was Vice President, Clinical Development & Regulatory Affairs at Cornerstone Therapeutics Inc.

Previously, Dr. Maetzel held a clinical development role at BioCryst, and also positions in strategy consulting and at Amgen.

Dr. Maetzel is a Visiting Scientist, Faculty of Medicine, University Hospital Zurich and Charité Hospital Berlin, and Adjunct Professor, Institute for Health Policy, Management & Evaluation, University of Toronto.

Dr. Maetzel obtained both a Ph.D and M.Sc. in Clinical Epidemiology from the University of Toronto and a Dr. med. at the University of Hannover, Germany.

 LATEST MOVES FROM Massachusetts 


 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy